Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Exclusion Criteria

• •History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematologic, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs; constituting a risk when taking the study intervention or interfering with the interpretation of data
• •History or presence of any form of asthma, including childhood asthma and exercise induced asthma
• •Current enrollment or past participation in this clinical study
• •Participants with clinically significant abnormalities
• •A positive pre-study drug/alcohol screen or a history (or suspected history) of alcohol misuse or substance abuse
• •Positive nasopharyngeal polymerase chain reaction test for severe acute respiratory syndrome-corona virus type 2 (SARS-CoV-2) on Day -1 or any known close contact with a person who tested positive for SARS-CoV-2 or with a coronavirus disease 2019 participant within 2 weeks prior to admission
• •Impairment which would prevent the correct and consistent use of an MDI, as determined by the investigator